GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Price-to-Tangible-Book

Corix Bioscience (Corix Bioscience) Price-to-Tangible-Book : 0.00 (As of Jun. 03, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Price-to-Tangible-Book?

As of today (2024-06-03), Corix Bioscience's share price is $0.0001. Corix Bioscience's Tangible Book per Share of Sep. 2017 for the quarter that ended in Sep. 2017 was $0.16. Hence, Corix Bioscience's Price to Tangible Book Ratio of today is 0.00.

The historical rank and industry rank for Corix Bioscience's Price-to-Tangible-Book or its related term are showing as below:

CXBS's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.33
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Corix Bioscience's share price is $0.0001. Corix Bioscience's Book Value per Sharefor the quarter that ended in Sep. 2017 was $0.17. Hence, Corix Bioscience's P/B Ratio of today is 0.00.


Corix Bioscience Price-to-Tangible-Book Historical Data

The historical data trend for Corix Bioscience's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Price-to-Tangible-Book Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - 444,444.44 2.14

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 2.14 - 2.96 7.06

Competitive Comparison of Corix Bioscience's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Price-to-Tangible-Book falls into.



Corix Bioscience Price-to-Tangible-Book Calculation

Corix Bioscience's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2017 )
=0.0001/0.16
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Corix Bioscience Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Corix Bioscience (Corix Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines